Search

everythinglearnresearchcommunity

for

Search:↓

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Finasteride and dutasteride can cause severe, lasting side effects.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Female pattern hair loss does not significantly affect sexual dysfunction.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.